Marizomib for Newly Diagnosed Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neuro-Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial
Neuro-oncology 2024 Mar 19;[EPub Ahead of Print], P Roth, T Gorlia, JC Reijneveld, F de Vos, A Idbaih, JS Frenel, E Le Rhun, JM Sepulveda, J Perry, GL Masucci, P Freres, H Hirte, C Seidel, A Walenkamp, S Lukacova, P Meijnders, A Blais, F Ducray, V Verschaeve, G Nicholas, C Balana, DA Bota, M Preusser, S Nuyens, F Dhermain, M van den Bent, CJ O'Callaghan, M Vanlancker, W Mason, M WellerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.